This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fundacao Oswaldo Cruz. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Débora Inácio Leite: Innovator in HIV Treatment
Introduction
Débora Inácio Leite is a prominent inventor based in Rio de Janeiro, Brazil. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for the treatment of HIV. Her innovative work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Débora holds a patent for isatin-derived compounds, which are used for the treatment of AIDS. The patent details the use of these compounds, which consist of various isatin derivatives, specifically designed to inhibit HIV. The compounds are represented by Formulae I, II, and III, where R is selected from H, CH, or Cl, and R is selected from radicals such as zidovudine, amprenavir, or an acyclic phosphonate chain. This invention also addresses the treatment of infections caused by HBV or co-infection with HIV and HBV.
Career Highlights
Débora is associated with the Fundação Oswaldo Cruz, a renowned research institution in Brazil. Her work there has focused on the development of innovative treatments for viral infections, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Mônica Macedo Bastos and Nubia Boechat, who have collaborated with her on various research projects. Their combined expertise has contributed to the success of their innovative endeavors.
Conclusion
Débora Inácio Leite's contributions to the field of HIV treatment through her patented compounds highlight her role as a leading inventor in medicinal chemistry. Her work not only advances scientific knowledge but also offers hope for improved treatment options for those affected by HIV and related infections.